Transgenomic (TBIO) Reports Q2 Loss of $0.10/Share

August 12, 2016 4:10 PM EDT

Get the Pulse of the Market with's Pulse Picks. Get your Free Trial here.

Transgenomic (NASDAQ: TBIO) reported Q2 EPS of ($0.10), versus ($0.26) reported last year.

For earnings history and earnings-related data on Transgenomic (TBIO) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment